# Oseltamivir

## Oseltamivir Phosphate 6mg/mL， 60mL oral suspension

| TAH Drug Code      | [LOSTAS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LOSTAS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of influenza in adults and children (including full-term newborns). Prevention of influenza in adults and children aged 1 and above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Treatment of influenza: must begin treatment within the first or second day of experiencing influenza symptoms. - Adults and adolescents (>=13years): 75mg PO BID for 5 days. - Children (dosages based on body weight): <=15kg: 30mg (5mL) PO BID for 5 days. >15-23kg: 45mg (7.5mL) PO BID for 5 days. >23-40kg: 60mg (10mL) PO BID for 5 days. >40kg: 75mg (12.5mL) PO BID for 5 days. - Children under 1 year: 3mg/kg PO BID for 5 days (not for infants with a gestational age of <36 weeks). Prophylaxis of influenza: must begin prophylaxis within 2 days of exposure to the source. - Adults and adolescents: 75mg PO QD for 10 or more days (safety and efficacy confirmed for 6 weeks). - Children (dosages based on body weight): <=15kg: 30mg (5mL) PO QD for 10 days. >15-23kg: 45mg (7.5mL) PO QD for 10 days. >23-40kg: 60mg (10mL) PO QD for 10 days. > 40kg: 75mg (12.5mL) PO QD for 10 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Known allergies to oseltamivir phosphate or any of its components.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Nausea (8-10%)， Vomiting (Adult and adolescent， 2-8%; pediatric， 8-16%)， Headache (Influenza treatment， 2%; influenza prophylaxis， 17%) Serious: Cardiac dysrhythmia， Erythema multiforme (Rare)， Facial swelling， Stevens-Johnson syndrome (Rare)， Toxic epidermal necrolysis (Rare)， Gastrointestinal hemorrhage， Hemorrhagic colitis， Hepatitis， Anaphylaxis (Rare)， Seizure， Abnormal behavior， Delirium                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oseltamivir-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## Eraflu 75mg (Government)

| TAH Drug Code      | [OERAF](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OERAF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis & treatment of influenza in adult & children.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | (仿單) Influenza: Treatment (for patients > 1 year): - Adult: Usual Dose for uncomplicated influenza of <48 hrs duration: 75 mg po BID x 5 days; complicated influenza in immunocompromised patients even if ill over 48 hrs: 75 mg po BID x 10 or more days. - Children > 40 kg: 75 mg BID x 5 days - Children > 23-40 kg: 60 mg BID x 5 days - Children > 15-23 kg: 45 mg BID x 5 days - Children <= 15 kg: 30 mg BID x 5 days - Infant 0-12 months: 3 mg/kg BID x 5 days Prophylaxis (for patients > 1 year): - Adults: 75 mg orally once daily for 10 days to 6 weeks. - Children > 40 kg: 75 mg QD x 10 days - Children > 23-40 kg: 60 mg QD x 10 days - Children > 15-23 kg: 45 mg QD x 10 days - Children <= 15 kg: 30 mg QD x 10 days - Infants 3-11 months: 3 mg/kg once daily (熱病) |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Common: Nausea (8-10%)， Vomiting (Adult and adolescent， 2-8%; pediatric， 8-16%)， Headache (Influenza treatment， 2%; influenza prophylaxis， 17%) Serious: Cardiac dysrhythmia， Erythema multiforme (Rare)， Facial swelling， Stevens-Johnson syndrome (Rare)， Toxic epidermal necrolysis (Rare)， Gastrointestinal hemorrhage， Hemorrhagic colitis， Hepatitis， Anaphylaxis (Rare)， Seizure， Abnormal behavior， Delirium                                                                                                                                                                                                                                                                                                                                                          |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oseltamivir-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

## Tamiflu 75mg (Private)

| TAH Drug Code      | [OTAM7](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTAM7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prophylaxis & treatment of influenza in adult & children.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | (仿單) Influenza: Treatment (for patients > 1 year): - Adult: Usual Dose for uncomplicated influenza of <48 hrs duration: 75 mg PO BID x 5 days; complicated influenza in immunocompromised patients even if ill over 48 hrs: 75 mg PO BID x 10 or more days. - Children > 40 kg: 75 mg BID x 5 days - Children > 23-40 kg: 60 mg BID x 5 days - Children > 15-23 kg: 45 mg BID x 5 days - Children < or = 15 kg: 30 mg BID x 5 days - Infant 0-12 months: 3 mg/kg BID x 5 days Prophylaxis (for patients > 1 year): - Adults: 75 mg orally once daily for 10 days to 6 weeks. - Children > 40 kg: 75 mg QD x 10 days - Children > 23-40 kg: 60 mg QD x 10 days - Children > 15-23 kg: 45 mg QD x 10 days - Children < or = 15 kg: 30 mg QD x 10 days - Infants 3-11 months: 3 mg/kg once daily (熱病) |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Tamiflu is contraindicated in patients known to be allergic to oseltamivir phosphate or any of its components.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common: Nausea (8-10%)， Vomiting (Adult and adolescent， 2-8%; pediatric， 8-16%)， Headache (Influenza treatment， 2%; influenza prophylaxis， 17%) Serious: Cardiac dysrhythmia， Erythema multiforme (Rare)， Facial swelling， Stevens-Johnson syndrome (Rare)， Toxic epidermal necrolysis (Rare)， Gastrointestinal hemorrhage， Hemorrhagic colitis， Hepatitis， Anaphylaxis (Rare)， Seizure， Abnormal behavior， Delirium                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Compatible – Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oseltamivir-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

